Eiger BioPharmaceuticals
Latest round
- Series A
Last raised
- Feb 2015
Total raised
- $19M
Investors
- 2
About Eiger BioPharmaceuticals
Founded in 2008 and headquartered in Palo Alto, California, Eiger BioPharmaceuticals is a biotechnology company focused on innovative therapeutic solutions for infectious diseases. Eiger has successfully completed 20 deals overall, reflecting its active engagement in the market.Eiger BioPharmaceuticals is dedicated to developing antiviral therapies that specifically target viral pathogens, aiming to provide effective treatment options for a range of viral infections. These therapies inhibit viral replication to reduce infection severity and improve patient outcomes.51 mn.Eiger BioPharmaceuticals is actively working on launching new antiviral products and expanding into additional geographic markets.00 mn obtained in November 2018, is intended to support these initiatives. The company aims to enhance its product pipeline and improve market penetration in North America and Europe by 2024. Eiger's strategy also involves leveraging its collaborations and partnerships to facilitate these growth efforts, ensuring the company remains at the forefront of therapeutic innovation.
Who invested in Eiger BioPharmaceuticals
2 investors across 3 rounds
See all investors in Eiger BioPharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Eiger BioPharmaceuticals
Who invested in Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals has 2 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Eiger BioPharmaceuticals raised?
Eiger BioPharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Eiger BioPharmaceuticals last raise money?
Eiger BioPharmaceuticals's most recent round on record is a Series A, in Feb 2015.
What does Eiger BioPharmaceuticals do?
Founded in 2008 and headquartered in Palo Alto, California, Eiger BioPharmaceuticals is a biotechnology company focused on innovative therapeutic solutions for infectious diseases.
Where is Eiger BioPharmaceuticals headquartered?
Eiger BioPharmaceuticals is headquartered in Palo Alto, US.
Which VCs invest in companies like Eiger BioPharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Eiger BioPharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Eiger BioPharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.